カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のメシル酸レンバチニブカプセル市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Lenvatinib Mesylate Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7903）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7903
■ 発行日：2023年9月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：101
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥494,160見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥741,240見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥988,320見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のメシル酸レンバチニブカプセル市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のメシル酸レンバチニブカプセルの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のメシル酸レンバチニブカプセル市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- メシル酸レンバチニブカプセルの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

メシル酸レンバチニブカプセル市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・4mg、10mg

用途別セグメント
・肝細胞がん、甲状腺がん

主要な市場プレーヤー
・Sun Pharm Inds Inc、Eisai Inc、Lepu Pharmaceuticals、Qilu Pharmaceutical、Yangtze River Pharmaceutical Group、Chia Tai Tianqing Pharmaceutical、Jiangxi Shanxiang Pharmaceutical、CSPC Ouyi Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Hunan Kelun Pharmaceutical、Chengdu Best Pharmaceutical、Simcere Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、メシル酸レンバチニブカプセル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なメシル酸レンバチニブカプセルメーカーの企業概要、2019年～2022年までのメシル酸レンバチニブカプセルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なメシル酸レンバチニブカプセルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別メシル酸レンバチニブカプセルの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのメシル酸レンバチニブカプセルのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのメシル酸レンバチニブカプセル市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびメシル酸レンバチニブカプセルの産業チェーンを掲載しています。
・第14、15章では、メシル酸レンバチニブカプセルの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– メシル酸レンバチニブカプセルの概要
– タイプ別分析（2018年vs2022年vs2029年）：4mg、10mg
– 用途別分析（2018年vs2022年vs2029年）：肝細胞がん、甲状腺がん
– 世界のメシル酸レンバチニブカプセル市場規模・予測
– 世界のメシル酸レンバチニブカプセル生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sun Pharm Inds Inc、Eisai Inc、Lepu Pharmaceuticals、Qilu Pharmaceutical、Yangtze River Pharmaceutical Group、Chia Tai Tianqing Pharmaceutical、Jiangxi Shanxiang Pharmaceutical、CSPC Ouyi Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Hunan Kelun Pharmaceutical、Chengdu Best Pharmaceutical、Simcere Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：4mg、10mg
・用途別分析2018年-2029年：肝細胞がん、甲状腺がん
・メシル酸レンバチニブカプセルの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・メシル酸レンバチニブカプセルのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・メシル酸レンバチニブカプセルのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・メシル酸レンバチニブカプセルの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・メシル酸レンバチニブカプセルの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Lenvatinib Mesylate Capsules
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Lenvatinib Mesylate Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 4 mg
1.3.3 10 mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Lenvatinib Mesylate Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hepatocellular Carcinoma
1.4.3 Thyroid Cancer
1.5 Global Lenvatinib Mesylate Capsules Market Size & Forecast
1.5.1 Global Lenvatinib Mesylate Capsules Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Lenvatinib Mesylate Capsules Sales Quantity (2018-2029)
1.5.3 Global Lenvatinib Mesylate Capsules Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sun Pharm Inds Inc
2.1.1 Sun Pharm Inds Inc Details
2.1.2 Sun Pharm Inds Inc Major Business
2.1.3 Sun Pharm Inds Inc Lenvatinib Mesylate Capsules Product and Services
2.1.4 Sun Pharm Inds Inc Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sun Pharm Inds Inc Recent Developments/Updates
2.2 Eisai Inc
2.2.1 Eisai Inc Details
2.2.2 Eisai Inc Major Business
2.2.3 Eisai Inc Lenvatinib Mesylate Capsules Product and Services
2.2.4 Eisai Inc Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eisai Inc Recent Developments/Updates
2.3 Lepu Pharmaceuticals
2.3.1 Lepu Pharmaceuticals Details
2.3.2 Lepu Pharmaceuticals Major Business
2.3.3 Lepu Pharmaceuticals Lenvatinib Mesylate Capsules Product and Services
2.3.4 Lepu Pharmaceuticals Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lepu Pharmaceuticals Recent Developments/Updates
2.4 Qilu Pharmaceutical
2.4.1 Qilu Pharmaceutical Details
2.4.2 Qilu Pharmaceutical Major Business
2.4.3 Qilu Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.4.4 Qilu Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Qilu Pharmaceutical Recent Developments/Updates
2.5 Yangtze River Pharmaceutical Group
2.5.1 Yangtze River Pharmaceutical Group Details
2.5.2 Yangtze River Pharmaceutical Group Major Business
2.5.3 Yangtze River Pharmaceutical Group Lenvatinib Mesylate Capsules Product and Services
2.5.4 Yangtze River Pharmaceutical Group Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
2.6 Chia Tai Tianqing Pharmaceutical
2.6.1 Chia Tai Tianqing Pharmaceutical Details
2.6.2 Chia Tai Tianqing Pharmaceutical Major Business
2.6.3 Chia Tai Tianqing Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.6.4 Chia Tai Tianqing Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
2.7 Jiangxi Shanxiang Pharmaceutical
2.7.1 Jiangxi Shanxiang Pharmaceutical Details
2.7.2 Jiangxi Shanxiang Pharmaceutical Major Business
2.7.3 Jiangxi Shanxiang Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.7.4 Jiangxi Shanxiang Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangxi Shanxiang Pharmaceutical Recent Developments/Updates
2.8 CSPC Ouyi Pharmaceutical
2.8.1 CSPC Ouyi Pharmaceutical Details
2.8.2 CSPC Ouyi Pharmaceutical Major Business
2.8.3 CSPC Ouyi Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.8.4 CSPC Ouyi Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
2.9 Jiangsu Aosaikang Pharmaceutical
2.9.1 Jiangsu Aosaikang Pharmaceutical Details
2.9.2 Jiangsu Aosaikang Pharmaceutical Major Business
2.9.3 Jiangsu Aosaikang Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.9.4 Jiangsu Aosaikang Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
2.10 Hunan Kelun Pharmaceutical
2.10.1 Hunan Kelun Pharmaceutical Details
2.10.2 Hunan Kelun Pharmaceutical Major Business
2.10.3 Hunan Kelun Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.10.4 Hunan Kelun Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hunan Kelun Pharmaceutical Recent Developments/Updates
2.11 Chengdu Best Pharmaceutical
2.11.1 Chengdu Best Pharmaceutical Details
2.11.2 Chengdu Best Pharmaceutical Major Business
2.11.3 Chengdu Best Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
2.11.4 Chengdu Best Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Chengdu Best Pharmaceutical Recent Developments/Updates
2.12 Simcere Pharmaceuticals
2.12.1 Simcere Pharmaceuticals Details
2.12.2 Simcere Pharmaceuticals Major Business
2.12.3 Simcere Pharmaceuticals Lenvatinib Mesylate Capsules Product and Services
2.12.4 Simcere Pharmaceuticals Lenvatinib Mesylate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Simcere Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Lenvatinib Mesylate Capsules by Manufacturer
3.1 Global Lenvatinib Mesylate Capsules Sales Quantity by Manufacturer (2018-2023)
3.2 Global Lenvatinib Mesylate Capsules Revenue by Manufacturer (2018-2023)
3.3 Global Lenvatinib Mesylate Capsules Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Lenvatinib Mesylate Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Lenvatinib Mesylate Capsules Manufacturer Market Share in 2022
3.4.2 Top 6 Lenvatinib Mesylate Capsules Manufacturer Market Share in 2022
3.5 Lenvatinib Mesylate Capsules Market: Overall Company Footprint Analysis
3.5.1 Lenvatinib Mesylate Capsules Market: Region Footprint
3.5.2 Lenvatinib Mesylate Capsules Market: Company Product Type Footprint
3.5.3 Lenvatinib Mesylate Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Lenvatinib Mesylate Capsules Market Size by Region
4.1.1 Global Lenvatinib Mesylate Capsules Sales Quantity by Region (2018-2029)
4.1.2 Global Lenvatinib Mesylate Capsules Consumption Value by Region (2018-2029)
4.1.3 Global Lenvatinib Mesylate Capsules Average Price by Region (2018-2029)
4.2 North America Lenvatinib Mesylate Capsules Consumption Value (2018-2029)
4.3 Europe Lenvatinib Mesylate Capsules Consumption Value (2018-2029)
4.4 Asia-Pacific Lenvatinib Mesylate Capsules Consumption Value (2018-2029)
4.5 South America Lenvatinib Mesylate Capsules Consumption Value (2018-2029)
4.6 Middle East and Africa Lenvatinib Mesylate Capsules Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2029)
5.2 Global Lenvatinib Mesylate Capsules Consumption Value by Type (2018-2029)
5.3 Global Lenvatinib Mesylate Capsules Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2029)
6.2 Global Lenvatinib Mesylate Capsules Consumption Value by Application (2018-2029)
6.3 Global Lenvatinib Mesylate Capsules Average Price by Application (2018-2029)
7 North America
7.1 North America Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2029)
7.2 North America Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2029)
7.3 North America Lenvatinib Mesylate Capsules Market Size by Country
7.3.1 North America Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2029)
7.3.2 North America Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2029)
8.2 Europe Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2029)
8.3 Europe Lenvatinib Mesylate Capsules Market Size by Country
8.3.1 Europe Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2029)
8.3.2 Europe Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Lenvatinib Mesylate Capsules Market Size by Region
9.3.1 Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Lenvatinib Mesylate Capsules Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2029)
10.2 South America Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2029)
10.3 South America Lenvatinib Mesylate Capsules Market Size by Country
10.3.1 South America Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2029)
10.3.2 South America Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Lenvatinib Mesylate Capsules Market Size by Country
11.3.1 Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Lenvatinib Mesylate Capsules Market Drivers
12.2 Lenvatinib Mesylate Capsules Market Restraints
12.3 Lenvatinib Mesylate Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Lenvatinib Mesylate Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lenvatinib Mesylate Capsules
13.3 Lenvatinib Mesylate Capsules Production Process
13.4 Lenvatinib Mesylate Capsules Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lenvatinib Mesylate Capsules Typical Distributors
14.3 Lenvatinib Mesylate Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Lenvatinib Mesylate Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Lenvatinib Mesylate Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sun Pharm Inds Inc Basic Information, Manufacturing Base and Competitors
Table 4. Sun Pharm Inds Inc Major Business
Table 5. Sun Pharm Inds Inc Lenvatinib Mesylate Capsules Product and Services
Table 6. Sun Pharm Inds Inc Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sun Pharm Inds Inc Recent Developments/Updates
Table 8. Eisai Inc Basic Information, Manufacturing Base and Competitors
Table 9. Eisai Inc Major Business
Table 10. Eisai Inc Lenvatinib Mesylate Capsules Product and Services
Table 11. Eisai Inc Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Eisai Inc Recent Developments/Updates
Table 13. Lepu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Lepu Pharmaceuticals Major Business
Table 15. Lepu Pharmaceuticals Lenvatinib Mesylate Capsules Product and Services
Table 16. Lepu Pharmaceuticals Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lepu Pharmaceuticals Recent Developments/Updates
Table 18. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Qilu Pharmaceutical Major Business
Table 20. Qilu Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 21. Qilu Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Qilu Pharmaceutical Recent Developments/Updates
Table 23. Yangtze River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 24. Yangtze River Pharmaceutical Group Major Business
Table 25. Yangtze River Pharmaceutical Group Lenvatinib Mesylate Capsules Product and Services
Table 26. Yangtze River Pharmaceutical Group Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 28. Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Chia Tai Tianqing Pharmaceutical Major Business
Table 30. Chia Tai Tianqing Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 31. Chia Tai Tianqing Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 33. Jiangxi Shanxiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Jiangxi Shanxiang Pharmaceutical Major Business
Table 35. Jiangxi Shanxiang Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 36. Jiangxi Shanxiang Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangxi Shanxiang Pharmaceutical Recent Developments/Updates
Table 38. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. CSPC Ouyi Pharmaceutical Major Business
Table 40. CSPC Ouyi Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 41. CSPC Ouyi Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 43. Jiangsu Aosaikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Jiangsu Aosaikang Pharmaceutical Major Business
Table 45. Jiangsu Aosaikang Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 46. Jiangsu Aosaikang Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 48. Hunan Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Hunan Kelun Pharmaceutical Major Business
Table 50. Hunan Kelun Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 51. Hunan Kelun Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hunan Kelun Pharmaceutical Recent Developments/Updates
Table 53. Chengdu Best Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Chengdu Best Pharmaceutical Major Business
Table 55. Chengdu Best Pharmaceutical Lenvatinib Mesylate Capsules Product and Services
Table 56. Chengdu Best Pharmaceutical Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Chengdu Best Pharmaceutical Recent Developments/Updates
Table 58. Simcere Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Simcere Pharmaceuticals Major Business
Table 60. Simcere Pharmaceuticals Lenvatinib Mesylate Capsules Product and Services
Table 61. Simcere Pharmaceuticals Lenvatinib Mesylate Capsules Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Simcere Pharmaceuticals Recent Developments/Updates
Table 63. Global Lenvatinib Mesylate Capsules Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Lenvatinib Mesylate Capsules Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Lenvatinib Mesylate Capsules Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Lenvatinib Mesylate Capsules, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Lenvatinib Mesylate Capsules Production Site of Key Manufacturer
Table 68. Lenvatinib Mesylate Capsules Market: Company Product Type Footprint
Table 69. Lenvatinib Mesylate Capsules Market: Company Product Application Footprint
Table 70. Lenvatinib Mesylate Capsules New Market Entrants and Barriers to Market Entry
Table 71. Lenvatinib Mesylate Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Lenvatinib Mesylate Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Lenvatinib Mesylate Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Lenvatinib Mesylate Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Lenvatinib Mesylate Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Lenvatinib Mesylate Capsules Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Lenvatinib Mesylate Capsules Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Lenvatinib Mesylate Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Lenvatinib Mesylate Capsules Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Lenvatinib Mesylate Capsules Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Lenvatinib Mesylate Capsules Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Lenvatinib Mesylate Capsules Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Lenvatinib Mesylate Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Lenvatinib Mesylate Capsules Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Lenvatinib Mesylate Capsules Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Lenvatinib Mesylate Capsules Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Lenvatinib Mesylate Capsules Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Lenvatinib Mesylate Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Lenvatinib Mesylate Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Lenvatinib Mesylate Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Lenvatinib Mesylate Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Lenvatinib Mesylate Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Lenvatinib Mesylate Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Lenvatinib Mesylate Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Lenvatinib Mesylate Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Lenvatinib Mesylate Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Lenvatinib Mesylate Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Lenvatinib Mesylate Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Lenvatinib Mesylate Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Lenvatinib Mesylate Capsules Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Lenvatinib Mesylate Capsules Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Lenvatinib Mesylate Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Lenvatinib Mesylate Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Lenvatinib Mesylate Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Lenvatinib Mesylate Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Lenvatinib Mesylate Capsules Raw Material
Table 131. Key Manufacturers of Lenvatinib Mesylate Capsules Raw Materials
Table 132. Lenvatinib Mesylate Capsules Typical Distributors
Table 133. Lenvatinib Mesylate Capsules Typical Customers
List of Figures
Figure 1. Lenvatinib Mesylate Capsules Picture
Figure 2. Global Lenvatinib Mesylate Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Lenvatinib Mesylate Capsules Consumption Value Market Share by Type in 2022
Figure 4. 4 mg Examples
Figure 5. 10 mg Examples
Figure 6. Global Lenvatinib Mesylate Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Lenvatinib Mesylate Capsules Consumption Value Market Share by Application in 2022
Figure 8. Hepatocellular Carcinoma Examples
Figure 9. Thyroid Cancer Examples
Figure 10. Global Lenvatinib Mesylate Capsules Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Lenvatinib Mesylate Capsules Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Lenvatinib Mesylate Capsules Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Lenvatinib Mesylate Capsules Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Lenvatinib Mesylate Capsules Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Lenvatinib Mesylate Capsules Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Lenvatinib Mesylate Capsules by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Lenvatinib Mesylate Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Lenvatinib Mesylate Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Lenvatinib Mesylate Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Lenvatinib Mesylate Capsules Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Lenvatinib Mesylate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Lenvatinib Mesylate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Lenvatinib Mesylate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Lenvatinib Mesylate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Lenvatinib Mesylate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Lenvatinib Mesylate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Lenvatinib Mesylate Capsules Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Lenvatinib Mesylate Capsules Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Lenvatinib Mesylate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Lenvatinib Mesylate Capsules Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Lenvatinib Mesylate Capsules Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Lenvatinib Mesylate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Lenvatinib Mesylate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Lenvatinib Mesylate Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Lenvatinib Mesylate Capsules Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Lenvatinib Mesylate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Lenvatinib Mesylate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Lenvatinib Mesylate Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Lenvatinib Mesylate Capsules Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Lenvatinib Mesylate Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Lenvatinib Mesylate Capsules Consumption Value Market Share by Region (2018-2029)
Figure 52. China Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Lenvatinib Mesylate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Lenvatinib Mesylate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Lenvatinib Mesylate Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Lenvatinib Mesylate Capsules Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Lenvatinib Mesylate Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Lenvatinib Mesylate Capsules Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Lenvatinib Mesylate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Lenvatinib Mesylate Capsules Market Drivers
Figure 73. Lenvatinib Mesylate Capsules Market Restraints
Figure 74. Lenvatinib Mesylate Capsules Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Lenvatinib Mesylate Capsules in 2022
Figure 77. Manufacturing Process Analysis of Lenvatinib Mesylate Capsules
Figure 78. Lenvatinib Mesylate Capsules Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のメシル酸レンバチニブ市場2023年：企業・地域・タイプ・用途別分析
  • 世界のデュタステリドソフトカプセル市場2023年：企業・地域・タイプ・用途別分析
  • 世界のダビガトランエテキシレートメシル酸API市場2023年：企業・地域・タイプ・用途別分析
  • 世界のエソメプラゾールマグネシウム腸溶カプセル市場2023年：企業・地域・タイプ・用途別分析
  • 世界のフルナリジン塩酸塩カプセル市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7903 )"世界のメシル酸レンバチニブカプセル市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Lenvatinib Mesylate Capsules Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。